H Pylori Stool Test Results: Positive and Retest Timing

Categories
Articles
H. pylori Testing Lab Interpretation 2026 Update Patient-Friendly

A positive stool antigen result usually means an active Helicobacter pylori infection; a reliable test-of-cure needs the right medication washout and timing.

📖 ~11 minutes 📅
📝 Published: 🩺 Medically Reviewed: ✅ Evidence-Based
⚡ Quick Summary v1.0 —
  1. Positive H pylori stool test usually means active infection, not old exposure, when the sample was collected correctly.
  2. Negative stool antigen is most reliable when you have been off PPIs or potassium-competitive acid blockers for at least 14 days.
  3. Antibiotics and bismuth can cause false negatives for about 4 weeks after the last dose.
  4. Test-of-cure timing should be at least 4 weeks after finishing antibiotics and at least 2 weeks after stopping acid suppression.
  5. Borderline or equivocal results should usually be repeated rather than treated as clearly positive or clearly negative.
  6. Blood antibody tests can stay positive for years and should not be used to prove eradication after treatment.
  7. Monoclonal stool antigen tests generally perform above 90% sensitivity and specificity in good laboratory conditions.
  8. Alarm symptoms such as black stools, vomiting blood, unexplained weight loss, or anemia need medical review rather than repeat stool testing alone.

What a positive H pylori stool test means

A positive H pylori stool test means Helicobacter pylori antigen was detected in stool and, in most untreated patients, this points to an active stomach infection. If you recently took antibiotics, bismuth, a proton pump inhibitor, or vonoprazan, the result still needs timing context before anyone calls it final.

Positive H pylori stool test shown as a sealed antigen kit beside a gastric bacteria model
Figure 1: A positive antigen result usually reflects active H. pylori infection.

The H pylori antigen test looks for bacterial proteins shed from the stomach into stool; it is not the same as an antibody test. A stool antigen test detects current infection more directly than a blood antibody test, which can remain positive for 6–24 months or longer after eradication.

In clinic, I treat a true positive as meaningful, especially when the patient has burning epigastric pain, iron deficiency, unexplained nausea, or a history of ulcer disease. Kantesti is an AI blood test interpretation platform that helps patients place related blood markers, such as hemoglobin, ferritin, B12, and inflammatory markers, beside the stool result rather than reading one line in isolation; our background is described on About Us.

As of June 7, 2026, major guidelines still recommend confirming H. pylori eradication after treatment, because symptoms alone miss persistent infection. The 2024 American College of Gastroenterology guideline states that proof of eradication should be obtained with stool antigen, urea breath testing, or biopsy-based testing after an appropriate washout period (Chey et al., 2024).

One nuance patients rarely hear: a positive result after a properly timed test-of-cure is more likely to mean treatment failure than reinfection. In adults in low-prevalence countries, annual reinfection after confirmed eradication is often below 2%, while failed eradication after first-line therapy can be 10–30% depending on antibiotic resistance.

Negative No antigen detected Usually no active H. pylori infection if PPIs were stopped for 14 days and antibiotics or bismuth for 4 weeks.
Positive Antigen detected Usually active H. pylori infection; discuss eradication therapy and future test-of-cure.
Borderline or equivocal Near assay cutoff Repeat under correct medication washout, often within 1–2 weeks or as advised by the lab.
Positive with alarm symptoms Any positive result plus red flags Needs clinician review; endoscopy may be more appropriate than relying on stool testing alone.

When a negative stool antigen result is trustworthy

A negative H pylori stool test is trustworthy only when the patient has avoided suppressive medicines long enough and the sample reached the lab in acceptable condition. The usual washout is 14 days for PPIs or vonoprazan and 4 weeks for antibiotics or bismuth.

Negative H pylori stool test scenario with suppressed bacteria and a medication washout calendar
Figure 2: Medication timing often decides whether a negative result can be trusted.

A negative result after correct preparation has good rule-out value, particularly when a modern monoclonal stool antigen assay is used. Gisbert, de la Morena, and Abraira reported high diagnostic accuracy for monoclonal stool antigen testing in their American Journal of Gastroenterology meta-analysis, with performance generally above 90% in untreated patients (Gisbert et al., 2006).

The thing is, I see false reassurance when a patient tests while taking omeprazole 20–40 mg daily or after a “just-in-case” antibiotic course. If the symptoms continue and the preparation was poor, repeating the test is more useful than arguing with the first result; the same logic applies to many labs discussed in our guide on repeating abnormal blood tests.

A negative stool antigen test does not explain every upper abdominal symptom. Reflux, gallbladder disease, celiac disease, functional dyspepsia, gastroparesis, medication irritation, and pancreatic disease can mimic H. pylori pain, and several need a different test pathway.

My practical rule is simple: if the pre-test probability is high and the negative test was done during acid suppression, I do not call H. pylori excluded. I call it unproven, then repeat the test after washout or use a urea breath test if access is faster.

How to read borderline or equivocal stool antigen results

A borderline H pylori stool test result means the measured antigen signal sits close to the laboratory cutoff, so the safest interpretation is usually “uncertain.” Borderline is not the same as weakly positive unless the reporting lab explicitly says so.

Borderline H pylori stool test result represented by an immunoassay analyzer and grey-zone sample
Figure 3: Equivocal results sit near the assay cutoff and need repeat testing.

Most stool antigen assays use an optical density or signal threshold chosen by the manufacturer and validated by the lab. A result just above or below that threshold can shift with sample dilution, transport time, diarrhea, or low bacterial load after partial treatment.

This is one of those areas where context matters more than the single word on the report. If a patient stopped antibiotics 10 days ago and the result is equivocal, I usually wait until the 4-week mark and repeat rather than treating immediately.

Patients often compare “borderline” stool results with borderline blood values, but the logic differs. Blood biomarkers have biological ranges; stool antigen cutoffs are assay-specific decision points, much like the interpretation problems we cover in borderline lab results.

A borderline result with a bleeding ulcer, gastric lymphoma concern, or persistent iron deficiency deserves clinician-led evaluation rather than repeated home testing. In those settings, endoscopy can sample the stomach directly and can look for complications at the same time.

Clearly negative Below lab cutoff Usually no detectable antigen if medication washout was correct.
Equivocal Near lab cutoff Repeat testing is preferred, especially after PPIs, antibiotics, bismuth, or diarrhea.
Low positive Just above cutoff May represent true infection, but timing and symptoms should guide the next step.
Positive plus red flags Any positive signal with alarm features Medical review is needed; stool antigen alone is not enough.

Medicines that can cause false negative stool tests

The medicines most likely to cause a false negative H pylori stool test are PPIs, potassium-competitive acid blockers such as vonoprazan, antibiotics, and bismuth. H2 blockers and ordinary antacids interfere less, but your clinician may still tailor the plan.

Medicines linked to false negative H pylori stool test results arranged beside a sealed kit
Figure 4: Acid suppression and antimicrobials can lower detectable H. pylori antigen.

PPIs such as omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole can reduce bacterial density and antigen shedding. A 14-day PPI washout is the standard practical minimum before stool antigen testing or urea breath testing.

Antibiotics can suppress H. pylori without clearing it, so stool antigen testing within 4 weeks of amoxicillin, clarithromycin, metronidazole, tetracycline, levofloxacin, or rifabutin may be falsely negative. Bismuth subsalicylate and bismuth subcitrate can do the same; I ask patients about “pink stomach tablets” because many do not think of bismuth as an antimicrobial.

Potassium-competitive acid blockers, often called PCABs, include vonoprazan and can suppress acid more strongly than many PPIs. The 2022 Maastricht VI/Florence consensus recommends avoiding PPIs before diagnostic testing and emphasizes medication washout when confirming eradication (Malfertheiner et al., 2022).

Long-term acid suppression has its own monitoring issues, including magnesium, B12, iron, kidney function, and infection risk in selected patients. If you use PPIs for months, our clinical team often points readers to long-term PPI labs when reviewing the broader health picture.

PPIs Stop about 14 days before test Can lower bacterial load and antigen shedding.
Vonoprazan or PCABs Stop about 14 days before test Strong acid suppression can produce false negative results.
Antibiotics Avoid for 4 weeks before test Temporary bacterial suppression can mask persistent infection.
Bismuth Avoid for 4 weeks before test Has anti-H. pylori activity and can reduce antigen detection.

When treatment follow-up testing becomes reliable

A follow-up H pylori stool test becomes reliable at least 4 weeks after finishing antibiotics and after at least 2 weeks off PPIs, PCABs, and usually bismuth. Testing earlier can create a false sense of cure.

Follow-up H pylori stool test kit shown after treatment with a clear medication washout setup
Figure 5: Test-of-cure needs both antibiotic and acid-suppression washout.

The 4-week antibiotic interval exists because bacterial suppression can outlast symptoms and can temporarily reduce stool antigen. If a patient finishes quadruple therapy on June 1, the earliest reasonable stool antigen test is around June 29, provided acid suppression has also been stopped for 14 days.

I sometimes see patients retest 3–5 days after the last pill because they want reassurance before travelling. That result is not useless if positive, but a negative result that early should not be used to prove eradication.

The same timing discipline applies to other retests: if the biology has not had time to reset, the lab number can mislead. For a broader discussion of realistic retest windows, see our guide to lab change timelines.

If symptoms are severe while waiting, clinicians may use H2 blockers such as famotidine, alginate therapy, or antacids as a bridge. Do not stop prescribed acid suppression after a bleeding ulcer or high-risk endoscopy finding without direct medical advice.

Too early 0–27 days after antibiotics Negative results may be unreliable.
Minimum retest window ≥4 weeks after antibiotics Acceptable if PPIs or PCABs were also stopped for 14 days.
Acid blocker washout ≥14 days off PPIs or PCABs Improves stool antigen and breath test accuracy.
High-risk symptoms Any timing Urgent review may be needed rather than waiting for a retest.

Stool antigen versus breath, blood, and endoscopy

The H pylori stool test and urea breath test both detect active infection, while blood antibody testing mainly detects exposure. Endoscopy-based tests are best when alarm symptoms, ulcer complications, or biopsy questions are present.

H pylori stool test compared with breath testing and endoscopy tools in a clinical scene
Figure 6: Different H. pylori tests answer different clinical questions.

Stool antigen testing is practical because it is non-invasive, does not require fasting in most labs, and can confirm cure when timed correctly. Urea breath testing is also accurate, but it needs a breath collection setup and can be harder to access in some regions.

Blood antibody testing has a narrow role because IgG can persist long after the organism is gone. A positive antibody test in 2026 cannot tell you whether today’s symptoms are due to active H. pylori, and it should not be used as a test-of-cure.

Kantesti's neural network does not diagnose H. pylori from a blood panel, and that boundary matters. It can, however, flag patterns that make gastric blood loss or malabsorption more plausible, which is why our gut blood test guide pairs GI symptoms with CBC, ferritin, B12, albumin, and inflammatory markers.

Endoscopy is the more complete test when the question is not just “is H. pylori present?” but “is there an ulcer, narrowing, cancer, bleeding source, or another diagnosis?” In adults aged 60 or older with new dyspepsia, many guidelines lean toward endoscopy rather than test-and-treat alone.

Sample collection details that change accuracy

Stool antigen accuracy depends on a clean sample, correct container, timely transport, and avoiding watery dilution when possible. A technically poor specimen can turn a good assay into an ambiguous result.

Sealed stool antigen collection container for an H pylori stool test on a clean laboratory bench
Figure 7: Collection and transport quality can shift antigen detection.

Most labs want a small stool sample placed into a sterile container without urine, toilet water, or disinfectant contamination. If the sample sits at room temperature for too long, antigen stability may fall depending on the transport medium and assay.

Watery diarrhea can dilute antigen and may trigger a lab rejection or a cautious interpretation. If the test is not urgent, I prefer repeating once the stool is formed, especially when the first result is borderline and symptoms have been present for months rather than hours.

Home collection is not the problem; careless handling is. Our article on stool change patterns explains why color, consistency, and timing sometimes change the choice between stool antigen, calprotectin, culture, and ova-and-parasite testing.

Do not scoop from toilet water, do not overfill the container, and do not freeze a sample unless the lab specifically instructs you to do so. Those boring details are where many false starts happen.

What usually happens after a positive result

After a positive H pylori stool test, treatment usually involves 10–14 days of combination therapy followed by a properly timed test-of-cure. The exact regimen should reflect local antibiotic resistance, allergies, prior macrolide exposure, and pregnancy status.

Treatment planning after a positive H pylori stool test with medication packs and a follow-up kit
Figure 8: Eradication therapy needs planned follow-up, not symptom guessing.

Many current regimens use bismuth quadruple therapy for 14 days: a PPI, bismuth, tetracycline, and metronidazole. Clarithromycin triple therapy is less favored in many regions unless susceptibility is known, because clarithromycin resistance can push failure rates above 15–20%.

Side effects are common but usually manageable: metallic taste, nausea, darker stools from bismuth, and loose stools are frequent. I warn patients before they start, because surprise side effects are a major reason people skip doses around day 5 or 6.

If bloating, early fullness, or nausea persists after eradication, that does not automatically mean treatment failed. H. pylori can coexist with reflux, IBS, lactose intolerance, or celiac disease, which is why our bloating lab guide separates gastric infection from broader digestive clues.

Do not start leftover antibiotics for a positive result. Partial treatment makes resistance more likely and can also create exactly the medication-timing mess that makes the follow-up stool antigen hard to interpret.

Symptoms that should not wait for another stool test

Alarm symptoms with possible H. pylori disease need medical review rather than repeated stool antigen testing. Black stools, vomiting blood, progressive swallowing trouble, persistent vomiting, unexplained weight loss, or anemia can signal ulcer bleeding or another serious cause.

Watercolor stomach lining illustration showing H pylori bacteria near an irritated gastric surface
Figure 9: H. pylori can injure the stomach lining and contribute to ulcers.

H. pylori is a major cause of peptic ulcer disease, and eradication reduces ulcer recurrence substantially. The infection is also classified as a carcinogenic risk factor for gastric cancer, although most infected people never develop cancer.

In my experience, the missed clue is often iron deficiency rather than pain. A 48-year-old with ferritin 8 ng/mL, mild anemia, and a positive stool antigen result deserves a different level of attention than a 25-year-old with occasional dyspepsia and normal blood counts.

If weight loss or anemia is part of the story, pair the stool result with a medical evaluation rather than trying supplements first. Our guide to unexplained weight loss labs explains why CBC, liver tests, inflammatory markers, thyroid tests, and iron studies may all matter.

Emergency symptoms are different from routine dyspepsia. Vomiting blood, fainting with black stools, severe persistent abdominal pain, or signs of dehydration should be treated as urgent, not as a reason to order a second home test.

Special situations: children, pregnancy, and older adults

Children, pregnant patients, and older adults need more cautious H. pylori decisions because symptoms, medication safety, and cancer-risk thresholds differ. A stool antigen result is useful, but it rarely carries the whole decision by itself.

H pylori stool test kits prepared for different patient ages in a calm hospital setting
Figure 10: Age and pregnancy status change the testing and treatment discussion.

In children, testing is usually targeted rather than done for vague abdominal pain alone. Pediatric guidelines often reserve H. pylori testing for ulcer disease or specific specialist-led scenarios, because finding the organism does not prove it caused every stomach ache.

During pregnancy, clinicians weigh symptom severity, ulcer risk, gestational timing, and drug safety before treating. Some antibiotics and bismuth products may be avoided, so a positive result should be discussed with the obstetric or primary care clinician rather than handled with a standard adult regimen.

In older adults, new dyspepsia carries a higher probability of structural disease. Many clinicians use age 60 as a threshold for considering endoscopy, particularly when appetite change, anemia, low albumin, or weight loss is present.

Basic labs can change the urgency of referral in these groups. For children, age-specific interpretation matters, and our pediatric lab range guide explains why adult CBC, ferritin, and liver ranges should not be copied onto a child’s report.

Blood markers that change how I read the stool result

Blood tests do not diagnose H. pylori, but CBC, ferritin, B12, albumin, CRP, and kidney markers can change how urgently a stool result should be handled. A positive stool antigen plus iron deficiency is clinically different from an isolated positive in a well patient.

AI blood test analyzer view paired with H pylori stool test context and iron marker samples
Figure 11: Blood markers can reveal complications that stool antigen cannot show.

Kantesti is an AI blood test analyzer that reads blood markers in context, so our AI may flag low ferritin, falling hemoglobin, or macrocytosis as follow-up clues when a patient also reports H. pylori. A ferritin below 15 ng/mL is strongly suggestive of depleted iron stores in most adults, even when hemoglobin is still normal.

H. pylori can contribute to iron deficiency through chronic gastritis, reduced acid-mediated absorption, and sometimes occult blood loss from ulcer disease. Our low ferritin GI guide covers why persistent low ferritin without heavy menstrual bleeding should prompt a digestive review.

The connection with B12 is less tidy, but chronic gastritis can reduce intrinsic-factor function and acid release in some patients. When B12 is borderline, I look for methylmalonic acid, MCV drift, neurological symptoms, diet pattern, metformin use, and PPI duration rather than blaming H. pylori automatically.

Kantesti's clinical standards are reviewed through our medical validation framework, but stool antigen interpretation still belongs with a clinician who can order treatment. AI can organize risk signals; it should not replace eradication prescribing or endoscopy decisions.

Persistent positive after treatment: failure or reinfection?

A persistent positive stool antigen test at the correct time usually means eradication failure, not immediate reinfection. Reinfection is possible, but in many adult populations it is much less common than treatment failure within the first year.

H pylori bacteria shown surviving after treatment in a molecular educational scene
Figure 12: Persistent antigen after treatment usually suggests eradication failure.

Treatment failure often reflects antibiotic resistance, missed doses, vomiting during therapy, under-dosing, or using a regimen poorly matched to local resistance. Clarithromycin exposure in the previous few years is a useful clue because it predicts a higher chance of clarithromycin-resistant H. pylori.

If the second test is positive, clinicians usually avoid simply repeating the same regimen. A salvage regimen may use different antibiotics, bismuth-based therapy, rifabutin-based therapy, or susceptibility-guided treatment where available.

Trend thinking helps here: symptoms, hemoglobin, ferritin, and stool antigen timing all sit on a timeline. Our lab trend graph guide shows how plotting dates can prevent the classic mistake of comparing tests collected under totally different conditions.

I ask patients to write down the exact last dose date of antibiotics, bismuth, PPI, and PCAB. That simple list often explains why one “failed” result was actually an invalidly timed retest.

A practical retest checklist before you send the sample

Before repeating an H pylori stool test, confirm four dates: last antibiotic, last bismuth, last PPI or PCAB, and planned sample collection. If those dates do not meet the 4-week and 2-week rules, rescheduling is often smarter than testing.

Hands preparing an H pylori stool test retest kit with blank clinical paperwork and storage bag
Figure 13: A simple pre-test checklist prevents many false negative results.

Checklist item 1: finish all eradication medicines, then wait at least 4 weeks after the final antibiotic dose. Checklist item 2: stop PPIs and PCABs for at least 14 days before collection, unless your clinician says the risk of stopping is too high.

Checklist item 3: avoid bismuth for 4 weeks before the test, because it has direct anti-H. pylori activity. Checklist item 4: collect the sample cleanly, close the container firmly, and follow the lab’s storage time exactly.

Kantesti AI can help organize blood reports and symptom-linked lab patterns, but the stool sample itself must be processed by a certified laboratory. If you are uploading related blood work, our PDF upload guide explains how reports are read safely and converted into structured interpretation.

One small patient trick: set a phone reminder for the earliest valid test date before you take the first antibiotic dose. People remember start dates better than stop dates, and the retest plan is much easier to protect when it is written down early.

Evidence, clinical standards, and Kantesti research links

The strongest H. pylori stool antigen guidance comes from gastroenterology guidelines and diagnostic accuracy studies, not from symptom response alone. Kantesti is an AI-powered blood test analysis tool used across international settings, and our medical content is aligned with physician review rather than automated keyword writing.

Clinical research desk linking H pylori stool test evidence with physician-reviewed lab interpretation
Figure 14: Guidelines and timing rules make stool antigen results clinically useful.

I, Thomas Klein, MD, have seen more harm from mistimed negative tests than from the stool antigen method itself. A good test done under bad medication conditions is still a bad clinical answer.

Our physicians and advisors review high-risk medical topics through the Medical Advisory Board, and Kantesti's AI engine is benchmarked under clinical review standards described in the AI benchmark. That matters because H. pylori often shows up beside anemia, B12 issues, kidney medication choices, and long-term PPI monitoring rather than as a neat single-result story.

Klein, T., & Kantesti Clinical AI Group. (2026). RDW Blood Test: Complete Guide to RDW-CV, MCV & MCHC. Zenodo. https://doi.org/10.5281/zenodo.18202598. ResearchGate | Academia.edu. The related clinical explainer is available in our RDW research guide.

Klein, T., & Kantesti Clinical AI Group. (2026). BUN/Creatinine Ratio Explained: Kidney Function Test Guide. Zenodo. https://doi.org/10.5281/zenodo.18207872. ResearchGate | Academia.edu. The companion article on kidney ratio interpretation is useful when eradication therapy, dehydration, or medication side effects complicate lab review.

Frequently Asked Questions

What does a positive H pylori stool test mean?

A positive H pylori stool test usually means active Helicobacter pylori infection because the test detects bacterial antigen in stool. It is different from a blood antibody test, which can stay positive for months or years after past infection. A positive result should be discussed with a clinician because treatment usually requires 10–14 days of combination therapy and a later test-of-cure.

How long after H pylori treatment should I retest?

Retesting is usually reliable at least 4 weeks after finishing antibiotics and at least 2 weeks after stopping PPIs or potassium-competitive acid blockers such as vonoprazan. Bismuth should also generally be avoided for 4 weeks before the test. Testing earlier can produce a false negative because the bacteria may be suppressed but not eradicated.

Can omeprazole cause a false negative H pylori stool test?

Yes, omeprazole and other PPIs can cause a false negative H pylori stool test by lowering bacterial density and antigen shedding. Most guidelines use a 14-day PPI washout before stool antigen or urea breath testing. If stopping acid suppression is unsafe because of ulcer bleeding risk or severe symptoms, the timing should be planned with a clinician.

What does borderline H pylori stool antigen mean?

A borderline or equivocal H pylori stool antigen result means the antigen signal was close to the laboratory cutoff. It should not be treated as definitely positive or definitely negative unless the lab gives that interpretation. Most clinicians repeat the test after proper medication washout, especially if PPIs were used within 14 days or antibiotics or bismuth within 4 weeks.

Is a negative H pylori stool test always accurate?

A negative H pylori stool test is not always accurate if it was collected during PPIs, vonoprazan, antibiotics, bismuth, or poor sample handling. With correct preparation and a modern monoclonal assay, stool antigen testing generally has sensitivity and specificity above 90% in untreated adults. If symptoms and risk factors strongly suggest H. pylori, a mistimed negative result should be repeated or checked with another active-infection test.

Can I use a blood test to prove H pylori is gone?

No, a blood antibody test should not be used to prove H. pylori eradication because antibodies can remain positive long after the organism is gone. A stool antigen test, urea breath test, or biopsy-based test is preferred for test-of-cure. The follow-up test should be done at least 4 weeks after antibiotics and after the correct acid-suppression washout.

What should I do if my stool test is positive again after treatment?

A positive H pylori stool test after correctly timed treatment follow-up usually suggests eradication failure rather than immediate reinfection. The next regimen should usually avoid repeating the same antibiotics, especially if clarithromycin or metronidazole resistance is possible. Your clinician may choose bismuth quadruple therapy, susceptibility-guided therapy, or another salvage regimen depending on your medication history and local resistance patterns.

Get AI-Powered Blood Test Analysis Today

Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.

📚 Referenced Research Publications

1

Klein, T., Mitchell, S., & Weber, H. (2026). RDW Blood Test: Complete Guide to RDW-CV, MCV & MCHC. Kantesti AI Medical Research.

2

Klein, T., Mitchell, S., & Weber, H. (2026). BUN/Creatinine Ratio Explained: Kidney Function Test Guide. Kantesti AI Medical Research.

📖 External Medical References

3

Malfertheiner P et al. (2022). Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut.

4

Chey WD et al. (2024). ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology.

5

Gisbert JP et al. (2006). Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. American Journal of Gastroenterology.

2M+Tests Analyzed
127+Countries
98.4%Accuracy
75+Languages

⚕️ Medical Disclaimer

E-E-A-T Trust Signals

Experience

Physician-led clinical review of lab interpretation workflows.

📋

Expertise

Laboratory medicine focus on how biomarkers behave in clinical context.

👤

Authoritativeness

Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.

🛡️

Trustworthiness

Evidence-based interpretation with clear follow-up pathways to reduce alarm.

🏢 Kantesti LTD Registered in England & Wales · Company No. 17090423 London, United Kingdom · kantesti.net
blank
By Prof. Dr. Thomas Klein

Dr. Thomas Klein is a board-certified clinical hematologist serving as Chief Medical Officer at Kantesti AI. With over 15 years of experience in laboratory medicine and a deep expertise in AI-assisted diagnostics, Dr. Klein bridges the gap between cutting-edge technology and clinical practice. His research focuses on biomarker analysis, clinical decision support systems, and population-specific reference range optimization. As CMO, he leads the triple-blind validation studies that ensure Kantesti's AI achieves 98.7% accuracy across 1 million+ validated test cases from 197 countries.

Leave a Reply

Your email address will not be published. Required fields are marked *